Literature DB >> 20172224

Modulation of the bovine innate immune response by production of 1alpha,25-dihydroxyvitamin D(3) in bovine monocytes.

C D Nelson1, T A Reinhardt, T C Thacker, D C Beitz, J D Lippolis.   

Abstract

In cattle, the kidney has been the only known site for production of 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] from 25-hydroxyvitamin D(3) [25(OH)D(3)] by 1alpha-hydroxylase (1alpha-OHase). Based on human studies, it was hypothesized that bovine monocytes could produce 1,25(OH)(2)D(3) upon activation and 1,25(OH)(2)D(3) would regulate expression of vitamin D-responsive genes in monocytes. First, the effects of 1,25(OH)(2)D(3) on bovine monocytes isolated from peripheral blood were tested. Treatment of nonstimulated monocytes with 1,25(OH)(2)D(3) increased expression of the gene for the vitamin D 24-hydroxylase (24-OHase) enzyme by 51+/-13 fold, but 1,25(OH)(2)D(3) induction of 24-OHase expression was blocked by lipopolysaccharide (LPS) stimulation. In addition, 1,25(OH)(2)D(3) increased the gene expression of inducible nitric oxide synthase and the chemokine RANTES (regulated upon activation, normal T-cell expressed and secreted) in LPS-stimulated monocytes 69+/-13 and 40+/-12 fold, respectively. Next, the ability of bovine monocytes to express 1alpha-OHase and produce 1,25(OH)(2)D(3) was tested. Activation of monocytes with LPS, tripalmitoylated lipopeptide (Pam3CSK4), or peptidoglycan caused 43+/-9, 17+/-3, and 19+/-3 fold increases in 1alpha-OHase gene expression, respectively. Addition of 25(OH)D(3) to LPS-stimulated monocytes enhanced expression of inducible nitric oxide synthase and RANTES and nitric oxide production in a dose-dependent manner, giving evidence that activated monocytes convert 25(OH)D(3) to 1,25(OH)(2)D(3). In conclusion, bovine monocytes produce 1,25(OH)(2)D(3) in response to toll-like receptor signaling, and 1,25(OH)(2)D(3) production in monocytes increased the expression of genes involved in the innate immune system. Vitamin D status of cattle might be important for optimal innate immune function because 1,25(OH)(2)D(3) production in activated monocytes and subsequent upregulation of inducible nitric oxide synthase and RANTES expression was dependent on 25(OH)D(3) availability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20172224     DOI: 10.3168/jds.2009-2663

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  23 in total

1.  Measuring bovine γδ T cell function at the site of Mycobacterium bovis infection.

Authors:  Rachel A Rusk; Mitchell V Palmer; W Ray Waters; Jodi L McGill
Journal:  Vet Immunol Immunopathol       Date:  2017-10-27       Impact factor: 2.046

2.  A preliminary analysis of the variation in circulating 25-hydroxycholecalciferol concentrations in peri-partum spring-calving dairy cows.

Authors:  Nicholas J Ryan; Amy Brewer; Aspinas Chapwanya; Cliona O'Farrelly; Erin J Williams; Alexander C O Evans; Marijke E Beltman; Kieran G Meade
Journal:  Vet Res Commun       Date:  2022-07-05       Impact factor: 2.459

3.  Differential chemokine and cytokine production by neonatal bovine γδ T-cell subsets in response to viral toll-like receptor agonists and in vivo respiratory syncytial virus infection.

Authors:  Jodi L McGill; Brian J Nonnecke; John D Lippolis; Timothy A Reinhardt; Randy E Sacco
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

Review 4.  Vitamin D signaling in the bovine immune system: a model for understanding human vitamin D requirements.

Authors:  Corwin D Nelson; Timothy A Reinhardt; John D Lippolis; Randy E Sacco; Brian J Nonnecke
Journal:  Nutrients       Date:  2012-03-15       Impact factor: 5.717

5.  In vivo activation of the intracrine vitamin D pathway in innate immune cells and mammary tissue during a bacterial infection.

Authors:  Corwin D Nelson; Timothy A Reinhardt; Donald C Beitz; John D Lippolis
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

6.  Regulation of Mycobacterium-specific mononuclear cell responses by 25-hydroxyvitamin D3.

Authors:  Corwin D Nelson; Brian J Nonnecke; Timothy A Reinhardt; W Ray Waters; Donald C Beitz; John D Lippolis
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

7.  Treatment of an intramammary bacterial infection with 25-hydroxyvitamin D(3).

Authors:  John D Lippolis; Timothy A Reinhardt; Randy A Sacco; Brian J Nonnecke; Corwin D Nelson
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

8.  Differential expression of cytokines in response to respiratory syncytial virus infection of calves with high or low circulating 25-hydroxyvitamin D3.

Authors:  Randy E Sacco; Brian J Nonnecke; Mitchell V Palmer; W Ray Waters; John D Lippolis; Timothy A Reinhardt
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

Review 9.  Neonatal calf infection with respiratory syncytial virus: drawing parallels to the disease in human infants.

Authors:  Randy E Sacco; Jodi L McGill; Mitchell V Palmer; John D Lippolis; Timothy A Reinhardt; Brian J Nonnecke
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

Review 10.  Targeting TLR2 for vaccine development.

Authors:  Afonso P Basto; Alexandre Leitão
Journal:  J Immunol Res       Date:  2014-06-26       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.